QHSLab (OTCMKTS:USAQ – Get Free Report) is anticipated to release its resultson Tuesday, November 17th. Analysts expect QHSLab to post earnings of ($0.01) per share and revenue of $0.30 million for the quarter.
QHSLab Price Performance
OTCMKTS USAQ opened at $0.32 on Tuesday. The business has a 50 day moving average price of $0.35 and a two-hundred day moving average price of $0.47. The stock has a market cap of $3.65 million, a PE ratio of 10.78 and a beta of 0.71. QHSLab has a fifty-two week low of $0.18 and a fifty-two week high of $1.14.
QHSLab Company Profile
QHSLab, Inc is a healthcare technology and diagnostic services company focused on supporting the identification and management of chronic health conditions. The company combines laboratory testing with clinical decision-support tools intended to help healthcare providers make more informed treatment decisions.
Its offerings include diagnostic testing services and related digital or analytical solutions designed for use by medical professionals. These tools are intended to provide clinical information that can assist with patient evaluation, monitoring and ongoing care.
QHSLab serves the healthcare market through provider-focused products and services.
Further Reading
- Five stocks we like better than QHSLab
- Wall Street May Be Making a Big Mistake With monday.com Stock
- Are These 2 Mid-Cap Growth Stocks Worth the Risk?
- Oklo Changes the Narrative: Does a Nuclear Stock Price Explosion Come Next?
- Cloudflare’s 20% Sell-Off May Have Created an Opening for Investors
Receive News & Ratings for QHSLab Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for QHSLab and related companies with MarketBeat.com's FREE daily email newsletter.
